Preemptive Local Anesthesia in Vaginal Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00318292|
Recruitment Status : Completed
First Posted : April 26, 2006
Results First Posted : March 18, 2009
Last Update Posted : November 18, 2010
|Condition or disease||Intervention/treatment||Phase|
|Pain, Postoperative||Drug: bupivacaine and epinephrine Drug: Placebo||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||90 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Preemptive Local Anesthesia in Vaginal Surgery, A Prospective, Randomised Trial|
|Study Start Date :||April 2006|
|Actual Primary Completion Date :||March 2008|
|Actual Study Completion Date :||March 2008|
Active preemptive local analgesia.
Drug: bupivacaine and epinephrine
20 ml of 0.5% bupivacaine with 1:200,000 epinephrine paracervical injection.
Placebo Comparator: Placebo
Placebo for preemptive local analgesia.
20 ml normal saline injection.
- Visual Analogue Scale (VAS) Pain Score [ Time Frame: 30 minutes post-op ]Visual Analogue Scale (VAS) pain score on a scale from 0 (None) to 10 (Worst) points.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00318292
|United States, Arizona|
|Scottsdale, Arizona, United States, 85259|
|Principal Investigator:||Jaime B. Long, M.D.||Mayo Clinic|